KLK3 and prostate carcinoma: In line with our conclusions, the American Cancer Society (ACS) recommends that men at average risk should be offered testing beginning at age 50, and that men at increased risk for prostate cancer, such as those with a history of the disease in a father or brother at a young age, should begin testing with both the prostate specific antigen blood test and the digital rectal examination at age 45, or even younger if they have multiple relatives with the disease.